还没完全盈利,信达生物离“大厂”还差关键两步?

财经大健康
03 Apr

主力产品的销售天花板越来越近,信达生物把增收希望放在了好几个篮子里,这是机会,更是考验文 |凌馨编 |王小图/视觉中国被寄望最早靠“卖药”扭亏的创新药企宣布盈利了。虽然不是严格意义上的盈利,也不是全靠卖药。在刚发布的2024年业绩公告中,信达生物宣布:2024年首次达成Non-IFRS(非国际财务报告准则)利润与EBITDA(税息折旧及摊销前利润)双指标转正。“我们提前一年实现了第一个公司的目标。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10